Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002075957 | SCV002424295 | likely benign | not provided | 2024-10-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003033334 | SCV003738391 | uncertain significance | Inborn genetic diseases | 2021-12-01 | criteria provided, single submitter | clinical testing | The c.818A>C (p.E273A) alteration is located in exon 7 (coding exon 6) of the WFS1 gene. This alteration results from a A to C substitution at nucleotide position 818, causing the glutamic acid (E) at amino acid position 273 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Juno Genomics, |
RCV004796710 | SCV005417079 | uncertain significance | Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome | criteria provided, single submitter | clinical testing | PM2_Supporting |